Kallikrein 9 Antikörper (C-Term) (Cy3)

Produktnummer ABIN8003939

Dieser Kaninchen Polyklonal Antikörper detektiert spezifisch Kallikrein 9 in FACS. Es zeigt Reaktivität gegenüber Proben von Human.

Kurzübersicht für Kallikrein 9 Antikörper (C-Term) (Cy3) (ABIN8003939)

Target: Kallikrein 9 (KLK9)

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Kallikrein 9 Antikörper ist konjugiert mit Cy3

Applikation: Flow Cytometry (FACS)

Produktdetails anti-Kallikrein 9 Antikörper (Cy3)

Bindungsspezifität: C-Term

Verwendungszweck: Anti-Kallikrein 9/KLK9 Antibody Cy3 Conjugated

Spezifität: No cross reactivity with other proteins.

Kreuzreaktivität (Details): No cross-reactivity with other proteins

Aufreinigung: Immunogen affinity purified.

Immunogen: A synthetic peptide corresponding to a sequence at the C-terminus of human Kallikrein 9.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Flow Cytometry, 1-3 μg/1x10⁶ cells

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.

Haltbarkeit: 12 months

Details zu Kallikrein 9

Target: Kallikrein 9 (KLK9)

Andere Bezeichnung: KLK9

Hintergrund:

Background: KLK9 (kallikrein-related peptidase 9) also known as kallikrein 9 or KLK-L3, belongs to the kallikrein subgroup of serine proteases, which have diverse physiologic functions in many tissues. The KLK9 gene contains 5 coding exons and is mapped to 19q13.41. The KLK9 gene is regulated by steroid hormones in a human breast cancer cell line. Yousef et al. (2001) performed a quantitative analysis of KLK9 expression in ovarian cancer. The results indicated thatKLK9 is under steroid hormone regulation in ovarian and breast cancer cell lines. KLK9 is a potential independent favorable prognostic marker for early-stage, low-grade, optimally debulked ovarian cancer patients.

Gene Full Name: kallikrein related peptidase 9

Sequence Similarities: Belongs to the peptidase S1 family. Kallikrein subfamily.

Gen-ID: 284366

UniProt: Q9UKQ9

Pathways: Komplementsystem